Listed

Acurx Pharmaceuticals, Inc.

ACXPNasdaqCIK 1736243HealthcareFiscal year ends Dec 31

Reports and events: 84 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Acurx Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-1416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-118064
2023-11-1316:05 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-018824
2023-11-0316:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-114274
2023-10-0216:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-105928
2023-08-1407:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-090878
2023-08-1116:05 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-014645
2023-06-2916:07 ETS-1Registration statement0001104659-23-076317
2023-06-2016:44 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-23-072936
2023-05-1716:19 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001104659-23-061848
2023-05-1207:00 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-009495
2023-04-2716:11 ETDEF 14AProxy statementPeriod 2023-06-150001104659-23-051339
2023-03-1607:22 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-033054
2023-03-1517:25 ET10-KAnnual reportPeriod 2022-12-310001558370-23-003929
2022-11-1407:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-117682
2022-11-1016:07 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-017408
2022-09-1416:06 ETS-1Registration statement0001104659-22-100019
2022-08-1516:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-091225
2022-08-1216:07 ET10-QQuarterly reportPeriod 2022-06-300001410578-22-002396
2022-07-2508:46 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.05 Item not in the standard list; 9.01 Financial statements and exhibits0001104659-22-082266
2022-06-0716:10 ET8-K5.07 Shareholder vote results0001104659-22-068951
2022-05-1107:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-058543
2022-05-1016:07 ET10-QQuarterly reportPeriod 2022-03-310001410578-22-001250
2022-04-2516:06 ETDEF 14AProxy statementPeriod 2022-06-070001104659-22-049621
2022-03-1707:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-034747
2022-03-1616:05 ET10-KAnnual reportPeriod 2021-12-310001410578-22-000399
2021-11-1606:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-139573
2021-11-1216:06 ET10-QQuarterly reportPeriod 2021-09-300001104659-21-138038
2021-08-1616:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-106315
2021-08-1316:06 ET10-QQuarterly reportPeriod 2021-06-300001104659-21-105074
2021-07-0616:21 ETSC 13DOwnership report, active investor0001104659-21-089430
2021-07-0616:20 ETSC 13DOwnership report, active investor0001104659-21-089429
2021-06-2917:00 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-21-086902
2021-06-1106:02 ETS-1/ARegistration statement, amended0001104659-21-079723
2021-05-2718:14 ETS-1Registration statement0001104659-21-072553

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:17 ET. Listed shows no prices and gives no investment advice.